Crawford Investment Counsel Inc. Buys Shares of 18,080 Ralliant Corporation $RAL

Crawford Investment Counsel Inc. purchased a new position in shares of Ralliant Corporation (NYSE:RALFree Report) in the third quarter, HoldingsChannel reports. The fund purchased 18,080 shares of the company’s stock, valued at approximately $791,000.

Several other hedge funds also recently made changes to their positions in RAL. Westfuller Advisors LLC acquired a new stake in shares of Ralliant in the third quarter valued at approximately $26,000. Manchester Capital Management LLC acquired a new position in Ralliant during the second quarter worth $29,000. UMB Bank n.a. acquired a new position in Ralliant during the third quarter worth $29,000. BOKF NA bought a new position in Ralliant in the third quarter valued at $29,000. Finally, Webster Bank N. A. bought a new position in Ralliant in the third quarter valued at $31,000.

Insider Buying and Selling at Ralliant

In other Ralliant news, SVP Karen M. Bick sold 5,485 shares of the business’s stock in a transaction that occurred on Tuesday, March 3rd. The stock was sold at an average price of $45.00, for a total transaction of $246,825.00. Following the transaction, the senior vice president owned 46,756 shares of the company’s stock, valued at $2,104,020. The trade was a 10.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Amir A. Kazmi acquired 2,545 shares of the company’s stock in a transaction on Friday, February 6th. The stock was acquired at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the purchase, the senior vice president directly owned 39,699 shares of the company’s stock, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 8,145 shares of company stock valued at $332,233 in the last three months.

Analyst Upgrades and Downgrades

Several brokerages have commented on RAL. Truist Financial cut their price target on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Royal Bank Of Canada decreased their price objective on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a research report on Friday, February 6th. Zacks Research lowered Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research report on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Ralliant has an average rating of “Hold” and an average target price of $50.50.

Read Our Latest Report on Ralliant

Ralliant Stock Performance

NYSE RAL opened at $42.34 on Monday. The firm has a market capitalization of $4.73 billion and a P/E ratio of 21.60. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. The firm’s fifty day moving average price is $48.24 and its two-hundred day moving average price is $46.76. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $57.02.

Ralliant (NYSE:RALGet Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.

Ralliant Profile

(Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Read More

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RALFree Report).

Institutional Ownership by Quarter for Ralliant (NYSE:RAL)

Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.